Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada - Concepedia

Concepedia

Publication | Open Access

Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada

DOI Full Paper Access

23

Citations

23

References

2021

Year

D. Debieuvre, Rosalyn A. Juergens, Bernard Asselain, Clarisse Audigier-Valette, J.B. Auliac, Fabrice Barlési, Nicolas Benoît, P. Bombaron, Charles Butts, A. Dixmier,

Abstract

OS rates in patients receiving nivolumab for previously treated advanced NSCLC in real-world clinical practice closely mirrored those in phase 3 studies, suggesting similar effectiveness of nivolumab in clinical trials and clinical practice.

References

	Year	Citations

Page 1